📺 Stream EntrepreneurTV for Free 📺

Ebola Vaccine Shown to Be 'Highly Effective' Interim analysis of a trial to protect against the deadly disease has been shown to, thus far, be successful.

By Catherine Clifford

entrepreneur daily

Opinions expressed by Entrepreneur contributors are their own.

WHO/S. Hawkey
Ebola vaccine lab

The world may well be rid of one of the most deadly, devastating diseases of our generation.

An interim analysis of a trial of a vaccine to protect against the deadly ebola virus has been called "highly effective," the World Health Organization announced today. The vaccine is made by Merck and was tested in Guinea.

"This is an extremely promising development," said Dr. Margaret Chan, director-general of the World Health Organization, said in a statement.

Despite the early signs of success of the new drug, the independent monitoring group that conducted the review recommended that the trial should continue.

Related: This MIT Grad Is Changing Medicine With a Needle-Covered Pill

So far, the vaccine has shown 100-percent efficacy in preventing ebola in individuals. More than 4,000 individuals have voluntarily received the rVSV-ZEBOV vaccine as part of the Phase 3 trial which began in March, according to Merck. In total, 9,000 individuals have received the vaccine across all three trials.

To completely eradicate the deadly disease -- which most recently swept through parts of Africa last year, devastating communities and killing thousands of people -- anyone who may have come in contact with an infected person would get vaccinated.

Ebola has infected 28,000 people and killed 11,000 of those in the last 20 months, according to a statement from Gavi, a global public-private partnership that works to get new vaccines to those who need them.

Related: Google's Next Goal: Trying to Improve Robot-Assisted Surgery

Gavi released a statement today pressing for the expeditious distribution of the ebola vaccine. The global organization also commended the international community for expediting processes to make this vaccine available.

"The consortium of partners should be congratulated on the remarkable speed with which it put together these important and practical trials," said Gavi CEO Dr. Seth Berkley, in a written statement. "The global community will rightly expect the pace – alongside a high level of diligence – to be maintained so that people in affected communities and others living in countries at risk of Ebola can have access to a vaccine as soon as possible."

Related: How One Man Brought Health Care to India's Poorest Populations
Catherine Clifford

Senior Entrepreneurship Writer at CNBC

Catherine Clifford is senior entrepreneurship writer at CNBC. She was formerly a senior writer at Entrepreneur.com, the small business reporter at CNNMoney and an assistant in the New York bureau for CNN. Clifford attended Columbia University where she earned a bachelor's degree. She lives in Brooklyn, N.Y. You can follow her on Twitter at @CatClifford.

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Business Ideas

63 Small Business Ideas to Start in 2024

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2024.

Side Hustle

These Coworkers-Turned-Friends Started a Side Hustle on Amazon — Now It's a 'Full Hustle' Earning Over $20 Million a Year: 'Jump in With Both Feet'

Achal Patel and Russell Gong met at a large consulting firm and "bonded over a shared vision to create a mission-led company."

Business News

These Are the 10 Most Profitable Cities for Airbnb Hosts, According to a New Report

Here's where Airbnb property owners and hosts are making the most money.

Side Hustle

How to Turn Your Hobby Into a Successful Business

A hobby, interest or charity project can turn into a money-making business if you know the right steps to take.

Starting a Business

This Couple Turned Their Startup Into a $150 Million Food Delivery Company. Here's What They Did Early On to Make It Happen.

Selling only online to your customers has many perks. But the founders of Little Spoon want you to know four things if you want to see accelerated growth.